6.3 (2.89%)
5.8 (2.66%) 4.36 pm | 30 Apr 2012 | Source: CNBC-Awaaz
D D Sharma of Risk Capital Advisors is of the view that one should buy Biocon. ...
10.54 am | 30 Apr 2012 | Source: CNBC-TV18
Biocon has target of Rs 228-225, says Sudarshan Sukhani of s2analytics.com....